BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Johnson & Johnson Vision Presents New Data on Silicone Hydrogel Contact Lens Muco-Adhesive Properties

  Johnson & Johnson Vision today presented new data at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Honolulu, Hawaii.

  May 1, 2018

   · 

  4 min read
• Policy

  MA & Associates, LLC Move Forward With Preliminary Review

  Pazoo, Inc. is pleased to announce that this week on May 2, there will be a preliminary State review that will inspect the MA & Associates, LLC testing laboratory.

  May 1, 2018

   · 

  1 min read
• Business

  Kezar Life Sciences Strengthens Management Team with the Appointments of Niti Goel, MD, as Chief Medical Officer and Marc Belsky as Chief Financial Officer

  Kezar Life Sciences announced the appointments of Niti Goel, MD, as Chief Medical Officer and Marc Belsky as Chief Financial Officer.

  May 1, 2018

   · 

  3 min read
• CRH Medical Corporation Announces Majority Purchase of Western Ohio Sedation Associates

  CRH Medical Corporation announces that it has completed an accretive transaction whereby CRH has acquired a 51% interest in a gastroenterology (“GI”) anesthesia practice in Dayton, Ohio.

  May 1, 2018

   · 

  3 min read
• Biotech Beach

  Case Report in Journal of Thoracic Oncology Demonstrates the Clinical Utility of Biocept’s Liquid Biopsy Test for Patient Diagnosed with Non-Small Cell Lung Cancer

  Biocept, Inc. announces the publication of a “letter to the editor” in a prominent lung cancer journal highlighting the clinical utility of its Target Selector™ ROS1 gene rearrangement test.

  May 1, 2018

   · 

  6 min read
• Biotech Bay

  Arixa Pharmaceuticals Completes $8 Million Seed Funding to Initiate Clinical Trial of Oral Avibactam Prodrug to Treat Drug-resistant Gram-negative Infections

  Advanced preclinical in vivo models have shown high levels of oral absorption

  May 1, 2018

   · 

  3 min read
• Business

  Entasis Therapeutics Appoints David C. Hastings to Board of Directors

  Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced the appointment of David C. Hastings to the company’s Board of Directors.

  May 1, 2018

   · 

  2 min read
• Business

  Minnetronix Announces Appointment of Elissa Lindsoe as Chief Financial Officer

  Lindsoe brings more than 25 years of experience and a proven track record of successful financial management and direction to the company

  May 1, 2018

   · 

  1 min read
• Pharm Country

  Geisinger President And CEO To Make Announcement At HLTH Conference

  David T. Feinberg, M.D., MBA, Geisinger president and CEO, will make a major announcement during his presentation at the HLTH Conference, on May 6th at the Aria in Las Vegas.

  May 1, 2018

   · 

  3 min read
• Business

  Arena Pharmaceuticals and Outpost Medicine Enter into Licensing Agreement for Undisclosed Novel Compound

  - Arena’s non-core, proprietary, preclinical compound provides strategic fit with Outpost Medicine’s expertise in developing products for genitourinary disorders

  May 1, 2018

   · 

  5 min read